Compare use cases
Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.
Pick from validated:
AI imaging triage for the acute stroke pathwayAI second reader for breast cancer screeningAutonomous diabetic retinopathy screening in primary carePre-operative risk-stratification model for major surgerySelf-referral assistant for NHS Talking TherapiesType-2 diabetes long-term outcome predictor
Clear selection| Autonomous diabetic retinopathy screening in primary care Netherlands | Type-2 diabetes long-term outcome predictor Netherlands | |
|---|---|---|
| Trust badge | Validated | Validated |
| Evidence strength | Robust evidence | Robust evidence |
| Pipeline stage | Validated | Validated |
| Intended use | Provides an autonomous screening decision for more-than-mild diabetic retinopathy from retinal fundus images, referring positive cases to ophthalmology. | Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification. |
| Specialty | Other | Endocrinology |
| Autonomy | Autonomous (acts without a human) | Informs a human (advisory) |
| Deployment | Active deployment | Active deployment |
| EU AI Act tier | High-risk | High-risk |
| EU MDR class | Class IIb | Not a device |
| CE marking | CE marked | Not required |
| NICE ESF tier | Tier C — treat / diagnose / calculate risk | Tier C — treat / diagnose / calculate risk |
| Headline metric | Sensitivity: 0.87 | AUC / AUROC: 0.82 |
| Subgroup assessed | Yes | Yes |